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Abstract
It has been previously shown that there are some interethnic differences in
susceptibility to malaria between two sympatric ethnic groups of Mali, the
Fulani and the Dogon. The lower susceptibility to Plasmodium falciparum malaria
seen in the Fulani has not been fully explained by genetic polymorphisms
previously known to be associated with malaria resistance, including haemoglo-
bin S (HbS), haemoglobin C (HbC), alpha-thalassaemia and glucose-6-phosphate
dehydrogenase (G6PD) deficiency. Given the observed differences in the distri-
bution of FccRIIa allotypes among different ethnic groups and with malaria
susceptibility that have been reported, we analysed the rs1801274-R131H
polymorphism in the FccRIIa gene in a study of Dogon and Fulani in Mali
(n = 939). We confirm that the Fulani have less parasite densities, less parasite
prevalence,more spleen enlargement and higher levels of total IgG antibodies (anti-
CSP, anti-AMA1, anti-MSP1 and anti-MSP2) and more total IgE (P < 0.05)
compared with the Dogon ethnic group. Furthermore, the Fulani exhibit higher
frequencies of the blood group O (56.5%) compared with the Dogon (43.5%)
(P < 0.001). With regard to the FccRIIa polymorphism and allele frequency, the
Fulani group have a higher frequency of the H allele (Fulani 0.474, Dogon 0.341,
P < 0.0001), which was associated with greater total IgE production (P = 0.004).
Our findings show that the FccRIIa polymorphism might have an implication in
the relative protection seen in the Fulani tribe, with confirmatory studies required
in other malaria endemic settings.
Introduction
Malaria is a public health problem in at least 90 countries
worldwide, putting 40% of the world’s population at risk.
Each year ~500 million individuals contract malaria leading
to ~1 million deaths annually with more than 90% of the
worldwidemalaria cases and deaths occurring in sub-Saharan
Africa [1]. Among the Plasmodium species (the causative
agents of malaria), Plasmodium falciparum is particularly
lethal most notably causing cerebral malaria [2]. Although
there are control programmes based on chemoprophylaxis,
case management and antivector strategies, there is much
interest in how humans have evolved to develop resistance
strategies. Some observations in particular demonstrated
differences in antibody production and resistance between
ethnic groups in West Africa [3–11].
During the past decade, there has been increased interest
in assessing the role of Fc receptors for IgG (FccRs) on
leucocytes, because these receptors provide an important
bridge between the humoral and cellular arms of the
immune response [12]. Among the three classes of FccR
(FccRI, FccRII and FccRIII), the low-affinity FccRII class
is the most broadly distributed. A polymorphism in
FccRIIa has been studied extensively [12, 13]. A point
mutation [A=>G (reference/alternative)] resulting in an
amino acid change at position 131, histidine (His131) to
arginine (Arg131), is located in the second extracellular
immunoglobulin-like domain of this receptor. This is
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critical for the binding of human IgG2 [13]. Human IgG2
binds efficiently to FccIIa-His/His131, but not to FccRIIa-
Arg/Arg131, although both FccRIIa allotypes interact
with IgG1 and IgG3. FccRIIa is particularly important in
this regard, because none of the other FccR classes bind
human IgG2 efficiently [12, 13].
Considerable differences in the distribution of FccRIIa
allotypes have been identified across different ethnic groups
[14]. This difference poses interesting questions concerning
the selective pressure that maintains this polymorphism in
the FccRIIa gene in human populations, as well as the
impact of the polymorphism on the outcome of infection
and clinical manifestation of the disease. The clinical
importance of the FccRIIa polymorphism has been eval-
uated for encapsulated bacterial infections, in which IgG2
plays a critical role in host defence. Several recent hospital-
based case–control studies have shown an association
between FccRIIa-His/His131 and protection from encap-
sulated bacterial infections, whereas the poorly IgG2-
binding allotype FccRIIa-Arg/Arg131 is associated with
increased susceptibility to these pathogens [15–18].
Despite its association with increased susceptibility to
encapsulated bacterial infections, the frequency of the
FccRIIa-Arg/Arg131 genotype remains relatively stable in
most human populations. This stability suggests that
infections that depend on IgG1 and IgG3 but not IgG2 to
mediate protective immunity may induce selection advan-
tage for the poorly IgG2-binding FccRIIa-Arg/Arg131
allotype. However, the potential association of FccRIIa-
Arg/Arg131 with protective immune responses against
infectious diseases that do not rely on IgG2, such as
P. falciparum infection, has not been studied.
Previously, the FccRIIa-Arg/Arg131 polymorphism has
been studied in the neighbouring Fulani and Dogon ethnic
groups in Mali and has been related to antibody production
[10]. This study was undertaken in asymptomatic subjects
belonging to both tribes and showed a marked difference in
allelic distribution, with the Fulani and Dogon having
more 131H/H and 131R/R genotypes, respectively [10].
Here, we test for an association of the FccRIIa-Arg/His131
polymorphism with malaria symptoms and severity and
antibody production in Fulani and Dogon in a meso-
endemic area of Mali.
Materials and methods
Study participants. The study was performed in a rural
village of Manteourou, Mali, that lies within the African
Sahel – a transition zone stretching east–west across Africa
between the Sahara desert and the southern savannah. The
region is characterized by a dry season from October to
May and a rainy season from June to October. Here, people
from the Dogon and Fulani ethnic groups live together
in sympatry within 0.5 km of each other. The
Dogon (n = 505, 53.8%) are farmers who migrated from
Bandiagara (110 km) to their present location 50 years
ago, while the Fulani (Fulani, n = 434, 46.2%) are cattle
breeders who migrated 200 years ago from the area of
Douentza situated 150 km from the study area. There is no
intermarriage between these two ethnic groups [7]. Two
cross-sectional surveys were performed, the first at the end
of the transmission or rainy season (October/November
2006) and the second during the dry season (March/April
2007). The study included unrelated healthy volunteers,
children and adults, males and females, belonging to both
ethnic groups. At each survey, we collected clinical (spleen
enlargement, axillary temperature, body weight) and
parasitological data (malaria parasite densities and species)
as well as blood samples.
Clinical information. Axillary temperature and spleen
size were measured in all participants. The spleen size was
scored by Hackett’s method and dichotomized as enlarged
or not enlarged [19]. Thick blood smears were collected
and stained with 3% Giemsa and examined for malaria
parasites. Parasites and leucocytes were counted. Parasite
densities were estimated using an assumed leucocyte count
of 7500 leucocytes per microlitre of blood [7]. A film was
determined to be negative if no parasites were identified in
the course of examining sufficient fields for a total of 300
leucocytes to be counted. Quality control through double
reading was also conducted on 10% of the slides randomly
selected by a separate physician. Parasitaemia was defined
as being present or absent. Clinical malaria was defined as
the presence of fever (axillary temperature of at least
37.5 °C) plus the presence of P. falciparum parasites on the
thick blood smear, in the absence of any other known
illnesses. Asymptomatic malaria was defined as the pres-
ence of P. falciparum parasites, but no clinical symptoms.
As this is a cross-sectional survey, there are no severe cases
of malaria. Volunteers were followed up for malaria
incidence by active and passive methods by the research
team, which included a physician and biologist based in
the health centre of the village of Manteourou.
Genotyping and immunoassays. All Genomic DNA sam-
ples (n = 939) underwent whole genome amplification by
(PEP) [20] before the Fc gamma RIIa rs1801274 SNP
(chromosome 1 161479745; H/R alleles, denoted here as
rs1801274-R131H) was genotyped [as part of an ongoing
project (see Maiga et al.)] [21] using the Sequenom iPLEX
MassArray platform [22–24]. Serum was separated from
clotted blood by centrifugation (12,000 rpm for 8 min)
and analysed by ELISA for antibodies against four malarial
antigens (AMA1, MSP119, MSP2 and CSP) plus total IgE.
The processing of the immunological assays has been
described earlier (Maiga et al.) [21]. The cut-off value for
each assay was determined by calculating the arithmetic
mean of the absorbance of negative control samples
obtained from European individuals who had never been
exposed to malaria and adding three standard deviations to
that value (mean OD+3SD). Using standard positive
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(Brefet4 pool, from Gambia [25]) and negative controls
(European pool), the positive–negative threshold baseline
was constructed using OD values obtained upon ELISA and
was used for calculation of the observed antibody titres as
described previously [25]. The titre values were log10-
transformed to symmetrize them for regression analysis.
Ethical clearance. The ethical clearance was obtained
through the Institutional Review Board of the University
of Mali. Treatment for malaria and other illnesses detected
during the course of the study was provided to the study
population at no cost to participants. Community permis-
sion was obtained according to the procedures described by
Diallo et al., in CID 2005 [26]. Individual written consent
was then obtained for each exam or blood collection from
the adult or from the child’s parent or caregivers.
Statistical analysis. The overall comparison between
Fulani and Dogon across different backgrounds and
phenotypic variables was performed using Pearson’s chi-
squared independence tests for categorical variables and the
Mann–Whitney–Wilcoxon rank-sum tests for continuous
quantitative variables. Genotypic deviations from Hardy–
Weinberg equilibrium (HWE) were assessed using a chi-
squared statistical test. The association analysis was carried
out by fitting a series of genetic models (additive,
dominant, recessive, heterozygous advantage and general)
to each SNP-phenotype data. The association strength of a
given SNP in relation to the phenotype was measured by
the minimum P-value across all tests performed for
association. The AMA1, MSP1, MSP2 and CSP assay
results were log10-transformed to obtain approximated
Gaussian distributions. All association analyses were
performed on each ethnic group separately. All analyses
were performed using the R statistical software (http://
www.r-project.org).
Results
Study population
The study enrolled 939 participants of which 53.8% were
Dogon and 46.2% are Fulani (Table 1). Data from each
ethnic group were suitably matched for age, gender and
seasonal distribution (all P-values >0.05). We observed a
significant difference in the frequency of the O blood group
(known to be protective against malaria [27]), which is
higher in the Fulani than Dogon (P < 0.001). This
difference is in keeping with measures of infection rate,
parasite density and parasite positivity, and clinical
malaria, which were marginally higher in Dogon compared
with Fulani. The proportion of persons with enlarged
spleen was significantly (P < 0.001) higher in the Fulani
(30.7%) than in the Dogon (8.8%) (see Table 1). Similar
results were obtained after adjusting for age, gender and
season (data not shown). The frequency of the sickle HbS-S
allele was low in both ethnic groups (Dogon 1.8%, Fulani
1.0%), and the HbC-A allele was rare in the Fulani (0.6%
versus Dogon 3.8%, P < 0.0001).
FccRIIa R131H genotyping
All individual of the two study groups were genotyped for
the G494A single-nucleotide polymorphism (R131H) in
the fccRIIa gene (rs1801274). There was no evidence of
deviation from HWE in Dogon (P = 0.719) or Fulani
(P = 0.443) ethnic groups at the polymorphism. As
expected, allele frequencies at the rs1801274-R131H
SNP were different between the ethnic groups (H
frequency: Dogon 0.341, Fulani 0.474, P < 0.0001).
While both ethnic groups showed a similar frequency of
heterozygotes (131R/H), there was a statistical significant
difference between them regarding the frequency of
homozygotes (Table 1). The 131 R/R genotype was
dominating among the Dogon, and the 131 H/H genotype
was more common in the Fulani (P < 0.0001).
Total IgG antibodies to AMA 1, MSP1, MSP2 and CSP, and
total IgE
As observed previously, all immunoassays showed greater
median levels in the Fulani (Table 1, P < 0.02). Multi-
variate analysis of immunoassays adjusting for age, gender
and season did not change this result (data not presented).
There is a high correlation between AMA1, MSP1, MSP2
and CSP (Spearman’s rho >0.3), consistent across both
ethnic groups (Table S1).
FccRIIa R131H and malariometric data
An association analysis between the malariometric data
(spleen enlargement. parasite positive, fever, asymptomatic
and clinical malaria) and rs1801274-R131H revealed a
marginal reduced risk on parasite positivity in the Fulani
(HH/RH versus RR OR 0.535, 95% CI 0.288–0.993,
P = 0.048), but not in the Dogon group (OR 1.067,
P = 0.807) (Table 2). In addition, there is some evidence
of reduced risk of asymptomatic malaria in both Dogon
(HH versus RH/RR OR, 0.361, 95% CI 0.133–0.981,
P = 0.046) and Fulani (additive H OR 0.630, 95% CI
0.427–0.929, P = 0.020) (Table 2).
FccRIIa R131H and distribution of antibodies
Comparing the effects of rs1801274-R131H genotypes on
(log10) total IgE revealed an effect in the Fulani ethnic
group (HH versus RH/RR, adjusted difference 0.129, 95%
CI 0.043–0.215, P = 0.004), but not Dogon (HH versus
RH/RR adjusted difference 0.080, P = 0.236) (Table 3
and Fig. 1). We compared the effects of genotypes on the
other antibodies. The analysis of CSP was the only one
where we obtained a significant result (Dogon HH versus
 2013 The Authors. Scandinavian Journal of Immunology published by John Wiley & Sons Ltd on behalf of Scandanavian Society of Immunology (SSI).
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Table 1 Study characteristics by ethnic group.
Dogon (n = 505, 53.8%) Fulani (n = 434, 46.2%)
P-valueN (median) % (range) N (median) % (Range)
Age (in months) (204) (24–744) (168) (24–900) 0.05
0–4 years old 64 12.6 65 15.0
5–9 years old 85 16.8 78 18.0 0.10
10–15 years old 86 17.0 93 21.4
>15 years old 270 53.5 198 45.6
Male 219 43.4 192 44.2 0.84
Rainy season 332 65.7 262 60.4 0.10
ABO blood group O 195 43.5 237 56.5 <103
Parasitological data
Parasite positivity 108 21.6 71 16.5 0.06
Pf density (0) (0–3,034,000) (0) (0–684,400) 0.02
Spleen enlargement 44 8.7 133 30.6 <106
Fever prevalence 68 13.5 38 8.8 0.03
Immunological data
AMA1 (1078) (0–72,770) (1742) (2–72,770) 103
MSP1 (467) (0–131,800) (2063) (19–356,900) <106
MSP2 (1427) (0–777,500) (3164) (49–777,500) <106
CSP (679) (75–779,700) (1338) (0–1,387,000) <106
Total IgE (1403) (0–21,780) (1662) (171–28,960) 0.02
Malaria
Clinical malaria 63 12.5 30 6.9
Asymptomatic 91 18.0 79 18.2
None 351 69.5 325 74.9 0.02
HbS
AA genotype 446 (96.3) 420 (97.9)
AS genotype 17 (3.7) 9 (2.1) 0.231
HbC
GG genotype 341 (92.4) 333 (99.1)
AG/AA genotypes 28 (7.6) 3 (0.9) <104
rs1801274-R131H
genotype
RR 204 (43.8) 123 (28.5)
RH 206 (44.2) 207 (48.0)
HH 56 (12.0) 101 (23.4) <106
H allele 159 (34.1) 204 (47.4) <104
Hyperparasitaemia: parasitemia density >10,000 parasites per microlitre; Parasite positivity: presence of one or more parasite per microlitre; Pf density:
number of parasite per microlitre; Spleen enlargement: presence of spleen enlargement; P-value was calculated from a c2 test for qualitative variables and a
Mann–Whitney U-test for continuous variables.
Table 2 The H allele frequency by phenotype. Allele frequencies and association analysis.
Phenotype
H allele frequency Association analysis
Dogon
(n = 505)
Fulani
(n = 434) Dogon Fulani
Control Case Control Case Genetic Model OR 95% CI P OR 95% CI P
Spleen enlargement 0.349 0.263 0.487 0.447 Additive H 0.672 0.397–1.138 0.139 0.855 0.634–1.155 0.308
Parasite positive 0.339 0.333 0.491 0.401 HH/RH versus RR 1.067 0.633–1.800 0.807 0.535 0.288–0.993 0.048
Fever 0.337 0.363 0.477 0.446 HH/HR versus RR 1.166 0.669–2.032 0.588 1.072a 0.492–2.335 0.861
Clinical malaria 0.344 0.385 0.495 0.450 HH/RH versus RR 1.269 0.655–2.460 0.479 0.653 0.270–1.576 0.343
Asymptomatic malaria 0.344 0.300 0.495 0.397 Additive H 0.361b 0.133–0.981 0.046 0.630 0.427–0.929 0.020
Any malaria 0.344 0.336 0.495 0.412 Additive H 0.984 0.706–1.370 0.922 0.686 0.485–0.971 0.033
OR, odds ratio; CI, confidence interval, adjusted for age group and season.
aOR RH versus other: 0.677 (0.336, 1.365) P = 0.276.
bEffect for HH versus other.
Bold values denotes very important results.
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RR, adjusted CSP difference 0.298, 95% CI 0.543 to
0.054, P = 0.017) (see Table S2).
Discussion
Our study confirms that malaria risk is lower in the Fulani
(compared with the Dogon) with observed lower parasite
prevalence and density, fewer cases of malaria episodes and
a higher prevalence of spleen enlargement. This result
supports findings from the Gambia [3], Burkina Faso [4–6]
and Sudan [28–30]. We also observed that the Fulani have
a higher frequency of blood group O, which is known to be
protective in malaria [27]. The Fulani group exhibits
increased antibody production compared with the neigh-
bouring ethnic group, also consistent with previous work
[7–11]. In general, the lower susceptibility to P. falciparum
malaria seen in the Fulani has not been fully explained by
gene polymorphisms previously known to be associated
with malaria resistance, including HbS, HbC, alpha-
thalassaemia, G6PD deficiency and HLA [31].
In this study, we have focused on FccRIIa, a low-affinity
Fc receptor (FcR), and an important protein in the host
defence against infection. FcRs belong to the family of
immune receptors, which includes T cell receptors, B cell
receptors and natural killer receptor [32]. The Dogon and
Fulani exhibited different frequencies of FccRIIaR131H
(rs1801274-R131H) genotypes and alleles. In particular,
the 131H/H genotype and H allele are more frequent in
the Fulani (the most protected group to malaria), and the
131R/R genotype and R allele are more frequent in the
Dogon (the most susceptible). This result confirms a
smaller study from the same geographical area [10], as well
as a Sudanese study comparing Fulani with non-Fulani
ethnic groups [29, 30]. However, a study performed in
neighbouring Burkina–Faso in Fulani and Mossi ethnic
groups did not find the same result. They showed that the
genotypes are equally distributed across the Fulani and
Mossi [33]. This discrepancy between the Malian and
Burkina Faso studies could be explained by the age
distributions of the study participants. Our study included
both children and adults, while in the Burkina study, only
adults more than 20 years old were enrolled. Another
explanation is the different malaria endemicities, with the
Mali study area being meso-endemic and Burkina Faso’s
hyperendemic.
FccRIIa has been studied directly in relation to malaria
susceptibility with some studies showing a protective effect
for the 131R/R genotype (R allele) and reducing the risk of
high-density parasitaemia [34, 35]. Similarly, three other
studies have demonstrated an increased risk with 131 H/H
genotype for severe, cerebral or placental malaria [36–38].
Our data show a potentially marginal 46.5% protective
effect of parasite positivity of the 131 R/R genotype in the
Fulani group, while there was no significant effect in the
Dogon. However, other studies have shown an opposite
effect in malaria phenotypes. A Ghanaian study performed
in a seasonal malaria transmission area, observed that the
131 R/R genotype was associated with susceptibility to
severe malarial anaemia and cerebral malaria (severe
malaria) [39]. These findings have been supported by
another study from the same country [40]. A study
performed in Sudan found that the 131 R/R genotype (R
allele) was significantly associated with the odds of severe
malarial disease when compared with that of mild malaria
[28]. Some of the differences in the results of these studies
may be due to study design, where some, like us, are
comparing the effect between ethnic groups while others
compare disease severity. All agree that this marker is
associated with malaria and even though the FccRIIa 131
polymorphism is known to be functional, the heterogeneity
Table 3 Association analysis between rs1801274-R131H and total IgE (after log10 transformation) in each ethnic group.
Population N
Mean Log10 total IgE
Adjusted differencea 95% CI P-valueHH genotype RR/RH genotypes
Dogon 505 3.083 3.171 0.080 0.213 to 0.052 0.236
Fulani 434 3.343 3.213 0.129 0.043–0.215 0.004
aafter adjusting for age group and season, further adjustment for blood group and asymptomatic malaria does not change the interpretation of the results.
Figure 1 The distribution of total IgE by rs1801274-R131H genotypes.
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of results suggests that there may be other polymorphisms
within the gene that modify the response. Alternatively, as
this receptor is responsive to different IgG subtypes, part of
the heterogeneity may be down to what antibodies are
being produced by individuals and they may also be under
some level of genetic control.
It is well established that the asexual blood stages of
malaria parasites are responsible for the pathology of the
disease and that antibodies play an important role in malaria
protection [41]. Cytophilic antibodies are thought to be
instrumental in protective immunity. Several sero-epidemi-
ological studies have indicated an association between
protection frommalarial infection or disease with antibodies
of IgG1 and IgG3 subclasses [42, 43]. In this study, we have
shown that Fulani have greater total IgG antibodies against
AMA-1, MSP-1, MSP-2 and CSP antigens and also higher
total IgE. In addition, we demonstrated that the 131 H/H is
associated with increased total IgE levels in the Fulani ethnic
group. In the same area, we have previously shown that the
Fulani have higher levels of all IgG antimalarial subclasses
except for IgG4, which was very low in both ethnic groups
[10]. The 131 H/H genotype and the H allele have been
shown to be associated with higher IgG1, IgG2 and IgG3
antibodies. IgG2 that is known to efficiently bind to the
FccRIIa 131H allele and has been suggest to be considered as
cytophilic in this setting [10, 44]. Another study has found
evidence of increased antibody (IgG1 and IgG3) production
in a non-Fulani ethnic group [28]. This discrepancy could be
due to the transmission period or the immune status of the
subjects at the time of enrolment. At the same time, this
study [28] found raised levels of IgG2 in Fulani associated
with the FccRIIa131HH genotype, as in a previous study in
Mali [10]. A case–control study performed in India found
that the high-affinity IgG2-binding 131 H/H genotype was
associated with protection from malaria [45]. In a longitu-
dinal study of the Fulani population resident in eastern
Sudan, it has been shown that the FccRIIa (CD32), HbAS
polymorphisms aswell asGMandKMallotypes of IgGdiffer
significantly between the Fulani and the others ethnic group
[28, 46, 47]. On the basis on these observations, it has been
hypothesized that the FccRIIa genotype and IgG subclass
pattern may contribute to the interethnic differences in the
malaria susceptibility observed in Fulani and non-Fulani.
The Fulani showed higher levels of antimalaria IgG1,
IgG2 and IgG3 antibodies, while IgG4 level was low and
similar in both ethnic group [10]. In the same area and
under similar conditions, another smaller study comparing
the impact of IL-4-590C/T transition on the levels of
P. falciparum-specific IgE, IgG, and IgG subclasses and
total IgE have shown significant higher antibody levels in
the Fulani than in the Dogon ethnic group [11]. Here also,
IgG4 antibody level was low and similar in both ethnic
groups [11].
Some studies have looked at the FccRIIa131 polymor-
phism in relation to pregnancy in malaria. For example, a
recent study performed in Saudi Arabia has shown that the
131 H/H genotype and H allele are associated with
protection in malaria-free controls, compared with asymp-
tomatic malaria infection in pregnant women who showed
an increase in the RR genotype and R allele [48].
Collecting such information in our setting would
allow us to see whether this effect could be replicated in
both our ethnic groups, which would help in implement-
ing and monitoring malaria research strategies in endemic
areas.
Conclusion
This study confirms that the Fulani ethnic group compared
with the Dogon is less susceptible to malaria. Our work
extends the previous finding that the FccRIIa HH131
genotype and the H131 allele are more prevalent in the
Fulani compared with the Dogon. We find that the FccRIIa
polymorphism is associated with differential IgE response
and reduced risk of mild malaria in the Fulani ethnic group.
We suggest that this polymorphism should be investigated
in follow-up studies inMali, as well as in other ethnic groups
in alternative settings, to confirm our findings.
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